Abraham Ceesay, CEO: Rapport Therapeutics RAPP Sell · Filed 02/19

Trade details

Type: Insider sale
Amount: $103,185.6
Shares · price: 3,552 sh · $29.05 a share
Held after: 558,528 sh
Stock: Rapport Therapeutics RAPP
Person: Abraham CeesayCEO
Trade date: 26/02/18
Filed: 26/02/19
Days to filing: 1 days

Sold 0.6% of holdings

Share of holding sold: 0.6%

Rapport Therapeutics trades, last 26 weeks

What else happened in Rapport Therapeutics around then

Filed or reported within 30 days of the trade day · 01/19~03/20

Abraham Ceesay's recent trades

Abraham CeesayCEO
Sell10b5-1 planRapport Therapeutics
Sell10b5-1 plan
Rapport Therapeutics
RAPP
$76.2K
1,952 sh
$76.2K
Filed 09/24
Traded 09/23
Abraham CeesayCEO
Sell10b5-1 planRapport Therapeutics
Sell10b5-1 plan
Rapport Therapeutics
RAPP
$8,570
215 sh
$8,570
Filed 09/24
Traded 09/23
Abraham CeesayCEO
Sell10b5-1 planRapport Therapeutics
Sell10b5-1 plan
Rapport Therapeutics
RAPP
$1,765
43 sh
$1,765
Filed 09/24
Traded 09/23
Abraham CeesayCEO
Planned sale10b5-1 planRapport Therapeutics
Planned sale10b5-1 plan
Rapport Therapeutics
RAPP
$4M
99,480 sh
$4M
Filed 06/29
Traded 06/29
Abraham CeesayDirector
Planned salePacira BioSciences
Planned sale
Pacira BioSciences
PCRX
$210.4K
9,039 sh
$210.4K
Filed 06/12
Traded 06/12

Abraham Ceesay, CEO — sold $103.2K of Rapport Therapeutics RAPP · 0.6% of holdings · 10b5-1 plan | Whalegun